Related Experiment Video
Updated: Jul 20, 2026
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
Immunopathogenesis and immunotherapy of multiple sclerosis
Bernhard Hemmer1, Stefan Nessler, Dun Zhou
1Neuroimmunology Group, Department of Neurology, Heinrich Heine-University, Düsseldorf, Germany. bernhard.hemmer@uni-duesseldorf.de
Nature Clinical Practice. Neurology
|August 26, 2006
Summary
Multiple sclerosis (MS) involves immune system dysfunction causing CNS damage. Research explores immune responses and new therapies for this chronic neurological disease.
Area of Science:
- Neuroimmunology
- Immunopathology
Background:
- Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease characterized by inflammation, demyelination, and axonal injury.
- The immune system plays a central role in MS pathogenesis, supported by the efficacy of immunomodulatory and immunosuppressive therapies.
Purpose of the Study:
- To review current knowledge on the immunopathogenesis of MS.
- To discuss animal models of MS and their relevance.
- To explore novel immunointerventional treatment strategies based on evolving pathogenetic concepts.
Main Methods:
- Review of current scientific literature on MS immunopathogenesis.
- Analysis of findings from animal models, such as experimental autoimmune encephalomyelitis (EAE).
- Evaluation of recent clinical trial data for new immunotherapeutic agents.
Main Results:
- Substantial progress has been made in understanding the immune response in MS.
- Animal models have advanced knowledge but also revealed differences compared to human MS.
- New immunotherapeutic agents are under active clinical evaluation.
Conclusions:
- The immune system is critical in MS pathogenesis.
- Understanding immune mechanisms is key to developing effective treatments.
- Evolving pathogenetic concepts are driving the development of new therapeutic strategies for MS.
More Related Videos
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:40Cell-mediated Immune Responses
Overview
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...